Screener
Lifecore Biomedical, Inc. LFCR Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Lifecore Biomedical, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001005286-26-000033
| (in thousands, except share and per share amounts) | Three months ended / June 30,2026 | Three months ended / May 25,2025 | Six months ended / June 30,2026 | Six months ended / May 25,2025 |
|---|---|---|---|---|
| Other income, net | 110 | 171 | 220 | 504 |
| Loss before income taxes | (6,133) | (1,114) | (21,070) | (15,891) |
| Income tax expense | (23) | (33) | (66) | (25) |
| Net loss | (6,156) | (1,147) | (21,136) | (15,916) |
| Preferred stock dividends | (924) | (852) | (1,831) | (1,689) |
| Accretion of preferred stock to redemption value | (47) | (48) | (94) | (96) |
| Loss available to common stockholders | $(7,127) | $(2,047) | $(23,061) | $(17,701) |
| Loss per share, basic and diluted | $(0.19) | $(0.06) | $(0.61) | $(0.48) |
Item 1. Financial
FAQ
- What is Lifecore Biomedical, Inc.'s net income?
- Lifecore Biomedical, Inc. (LFCR) reported net income of -$6.16M in Q2 2026.
- What is the long-term trend for Lifecore Biomedical, Inc.'s net income?
- Over 2 years (2022 to 2025), Lifecore Biomedical, Inc.'s net income has grown at a -42.4% compound annual growth rate (CAGR), from -$116.72M to -$38.72M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Lifecore Biomedical, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude